Correlation Between Tempest Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Tempest Therapeutics and Eliem Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tempest and Eliem is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 0.95 times more return on investment than Eliem Therapeutics. However, Tempest Therapeutics is 1.06 times less risky than Eliem Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.38 per unit of risk. If you would invest 106.00 in Tempest Therapeutics on August 25, 2024 and sell it today you would lose (15.00) from holding Tempest Therapeutics or give up 14.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Tempest Therapeutics vs. Eliem Therapeutics
Performance |
| Timeline |
| Tempest Therapeutics |
| Eliem Therapeutics |
Tempest Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. RenovoRx | Tempest Therapeutics vs. Scpharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |